Treat this as a time capsule of sorts. Edits to come
AgriG8 - Unlocking capital for climate-resilient farmers
Iโm responsible for driving the pilot(s), and I take charge of our products as we build them from 0 to 1. I lead a team of designers and work closely with my software lead and the executive team. Weโre building up much needed financial infrastructure for unbanked rice farmers in SEA and beyond, and opening the gate to enabling carbon credit and sustainability-linked loans in the sector.
X0PA - The World's Most Objective Hiring Platform
X0PA is building the world's most objective hiring platform. I love the team so much, and I genuinely wish them all the success in the world.
The main product I managed was the AI Internship Placement System, which is currently live in two polys in Singapore.
<aside> ๐ฆด Be a Biomedical Engineering student (and researcher) in NUS Engineering
</aside>
I graduated with a B.Eng and dropped out of my M.Eng (I was attempting to do research on microfluidic devices to optimise chemotherapeutic dosage at the Micro-Tissue Engineering Lab).
<aside> ๐ Lead YSI SEA and its three innovation programmes as the COO
</aside>
Our mission was to empower Southeast Asian youth to solve sustainability challenges. We created online-offline hybrid innovation programmes (before COVID made it cool).
<aside> ๐งซ Do business development for biotech company Cellivate Technologies
</aside>
Cellivate Technologies developed and patented nanotechnology that enables cells to adhere better and accelerate their growth while maintaining vital cellular markers.
<aside> ๐ค Coach Negotiation in Tembusu College and NUS Business School
</aside>
I coached and coordinated the Heart of Negotiation Workshop, and assisted in BMA5406: Negotiations and Conflict Management.
<aside> ๐ฅผ Intern in Robert Bosch (SEA) Corporate Research and Bio3D Technologies
</aside>
I did research on point-of-care sensors for ions in blood, and did product development for a portable 3D-bioprinter.
<aside> โ๐พ Write for Biotechin.Asia, which is focused on biotech and healthcare news.
</aside>
I wrote about open access bio- and med-tech, along with some other topics.